Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
1.770
+0.560 (46.28%)
At close: Feb 21, 2025, 4:00 PM
1.750
-0.020 (-1.13%)
After-hours: Feb 21, 2025, 7:59 PM EST
Invivyd Employees
As of December 31, 2023, Invivyd had 95 total employees, including 94 full-time and 1 part-time employees. The number of employees increased by 9 or 10.47% compared to the previous year.
Employees
95
Change (1Y)
9
Growth (1Y)
10.47%
Revenue / Employee
$121,726
Profits / Employee
-$2,369,853
Market Cap
211.72M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 95 | 9 | 10.47% |
| Dec 31, 2022 | 86 | -17 | -16.50% |
| Dec 31, 2021 | 103 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
IVVD News
- 12 days ago - Invivyd to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025 - GlobeNewsWire
- 17 days ago - Invivyd Announces Partnership with Pro Football Coach Jim Harbaugh to Elevate Awareness and Ongoing Impact of COVID-19: Common, Not A Cold - GlobeNewsWire
- 17 days ago - I See The Bull Case For Invivyd, But I'm Not Married To It - Seeking Alpha
- 19 days ago - Invivyd Announces Preliminary Fourth Quarter 2024 Financial Results, Strong Revenue Growth, and Reiterates Goal of Near-Term Profitability - GlobeNewsWire
- 26 days ago - Invivyd Provides Another Positive SARS-CoV-2 Variant Data Analysis to Satisfy U.S. FDA's Gating Request for Completing Its Review of EUA Request for PEMGARDA™ (pemivibart) for the Treatment of Mild-to-Moderate COVID-19 in Certain Immunocompromised Patients - GlobeNewsWire
- 6 weeks ago - Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Dominant SARS-CoV-2 Variant XEC - GlobeNewsWire
- 3 months ago - Invivyd, Inc. (IVVD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Invivyd Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire